President Trump is very excited about hydroxychloroquine as a treatment for COVID-19, frequently touting it as a "game changer," and he isn't alone in his enthusiasm. His economic adviser Peter Navarro, who reportedly sparred with top U.S. infectious disease expert Dr. Anthony Fauci about hydroxychloroquine, told Fox & Friends on Monday morning he would "bet on President Trump's intuition on this." Other boosters Trump is apparently listening to include his lawyer Rudy Giuliani and Dr. Mehmet Oz, the controversial television personality.
At Sunday night's press briefing, Trump said he hopes doctors use the drug, "because I'll tell you what, what do you have to lose?" He added: "I may take it. I'll have to ask my doctors about that." When a reporter asked Fauci about hydroxychloroquine, Trump stepped in and shut it down.
Most health officials and medical scientists, like Fauci, are unconvinced about the malaria drug's effectiveness at treating the coronavirus, noting that the evidence so far is anecdotal and contradictory. "I think we've got to be careful that we don't make that majestic leap to assume that this is a knockout drug," Fauci said on Friday's Fox & Friends. Hydroxychloroquine also has heath risks, including cardiac arrest in some cases.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Giuliani has been pushing hydroxychloroquine on Twitter, his podcast, and, he tells The Washington Post, in one-on-one calls with Trump. He said he has no financial stake in hydroxychloroquine. After watching Dr. Oz repeatedly tout the drug on Fox News, Trump said he wants to speak with Oz and told health officials it would be "a good idea" if they did, too, The Daily Beast reports. At least one official, Medicare administrator Seema Verma, spoke with Oz privately.
In mid-March, Reuters reports, "Trump personally pressed federal health officials" to green-light hydroxychloroquine as a COVID-19 treatment, and "shortly afterward, the federal government published highly unusual guidance informing doctors they had the option to prescribe the drugs, with key dosing information based on unattributed anecdotes rather than peer-reviewed science." When asked about its guidance, the Centers for Disease Control and Prevention said Trump's coronavirus task force had requested the document.
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.